Develops innovative precision medicines and a pipeline of differentiated therapies targeting immuno-oncology, autoimmune disorders, and infectious diseases. Focuses on advancing treatments from proof-of-concept through commercialization to address difficult-to-treat diseases with high unmet patient need.